MBOA-6 (Membrane-bound O-acyltransferase 6) is a member of the MBOAT enzyme family. Key findings include:
Function: Facilitates the incorporation of polyunsaturated fatty acids (PUFAs) into phosphatidylcholine (PC), phosphatidylserine (PS), and phosphatidylethanolamine (PE) via lysophospholipid acyltransferase activity .
Knockdown Effects:
Structural Role: Part of a conserved enzyme family with transmembrane domains and a catalytic histidine residue .
| Parameter | Observation in mboa-6 Knockdown/RNAi | Citation |
|---|---|---|
| PUFA incorporation | Reduced in PC, PS, PE | |
| TRPV4 channel activity | Decreased response to GSK101 | |
| Embryonic viability | Lethal in null mutants |
This small molecule, distinct from the MBOA-6 enzyme, is a plant secondary metabolite studied for its effects on rodents and microbes:
Reproductive Effects:
Microbial/Metabolic Effects:
Anti-inflammatory Properties: Reduces iNOS expression in vitro .
Antibody-Specific Data: None of the sources describe an antibody targeting MBOA-6. The term "MBOA-6" exclusively refers to either an enzyme or the phytochemical 6-MBOA.
Potential Confusion: The query may conflate "MBOA-6" (enzyme) with "6-MBOA" (compound). Antibodies targeting the latter are not documented in the provided materials.
Commercial Antibodies: Result references an anti-integrin α6 antibody (clone NKI-GoH3), which is unrelated to MBOA-6.
Clarify Target: Confirm whether the focus is on the enzyme (MBOA-6) or the compound (6-MBOA).
Antibody Development: If targeting the enzyme, consult specialized antibody databases (e.g., CiteAb, Antibody Registry) for existing products.
Functional Studies: For 6-MBOA, explore its interactions with immune or metabolic pathways using validated antibodies against related biomarkers (e.g., iNOS ).